A Stronger Innate Immune Response During Hyperacute HIV-1 Infection is associated with ACUTE retroviral syndrome

Amin S Hassan, Jonathan Hare, Kamini Gounder, Jamirah Nazziwa, Sara Karlson, Linnéa Olsson, Claire Streatfield, Anatoli Kamali, Etienne Karita, William Kilembe, Matt A Price, Persephone Borrow, Per Björkman, Pontiano Kaleebu, Susan Allen, Eric Hunter, Thumbi Ndung'u, Jill Gilmour, Sarah Rowland-Jones, Joakim EsbjörnssonEduard J Sanders

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review


BACKGROUND: Acute retroviral syndrome (ARS) is associated with HIV-1 subtype and disease progression, but the underlying immunopathological pathways are poorly understood. We aimed to elucidate associations between innate immune responses during hyperacute HIV-1 infection (hAHI) and ARS.

METHODS: Plasma samples obtained from volunteers (≥18.0 years) before and during hAHI, defined as HIV-1 antibody negative and RNA or p24 antigen positive from Kenya, Rwanda, Uganda, Zambia and Sweden were analysed. Forty soluble innate immune markers were measured using multiplexed assays. Immune responses were differentiated into volunteers with stronger and comparatively weaker responses using principal component analysis. Presence or absence of ARS was defined based on eleven symptoms using latent class analysis. Logistic regression was used to determine associations between immune responses and ARS.

RESULTS: Of 55 volunteers, 31 (56%) had ARS. Volunteers with stronger immune responses (n=36 [65%]) had increased odds of ARS which was independent of HIV-1 subtype, age, and risk group (adjusted odds ratio, 7.1 [95% CI: 1.7-28.8], p=0.003). IP-10 was fourteen-fold higher during hAHI, elevated in seven of the eleven symptoms, and independently associated with ARS. IP-10 threshold >466.0 pg/mL differentiated stronger immune responses with a sensitivity of 84.2% (95% CI: 60.4-96.6) and specificity of 100.0% (95% CI: 90.3-100.0).

CONCLUSIONS: A stronger innate immune response during hAHI was associated with ARS. Plasma IP-10 may be a candidate biomarker of stronger innate immunity. Our findings provide further insights on innate immune responses in regulating ARS and may inform the design of vaccine candidates harnessing innate immunity.

Sidor (från-till)832-841
TidskriftClinical Infectious Diseases
Tidigt onlinedatum2021 feb. 15
StatusPublished - 2021

Ämnesklassifikation (UKÄ)

  • Mikrobiologi inom det medicinska området
  • Immunologi inom det medicinska området
  • Infektionsmedicin


Utforska forskningsämnen för ”A Stronger Innate Immune Response During Hyperacute HIV-1 Infection is associated with ACUTE retroviral syndrome”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här